You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 4
  • 366 Feasibility study of a network meta-analysis and unanchored population-adjusted indirect treatment comparison of niraparib, olaparib, and bevacizumab as maintenance therapies in patients with newly diagnosed advanced ovarian cancer

Article metrics

Article menu

Download PDFPDF

Ovarian cancer
366 Feasibility study of a network meta-analysis and unanchored population-adjusted indirect treatment comparison of niraparib, olaparib, and bevacizumab as maintenance therapies in patients with newly diagnosed advanced ovarian cancer
Free

 

Online download statistics by month:

Online download statistics by month: December 2020 to April 2024

AbstractFullPdf
Dec 2020134024
Jan 2021100038
Feb 202160026
Mar 202182019
Apr 202166012
May 20211405
Jun 2021009
Jul 20210012
Aug 20210018
Sep 20210016
Oct 202138028
Nov 202152020
Dec 20211705
Jan 202238012
Feb 20223608
Mar 20223008
Apr 20222803
May 202226011
Jun 20221102
Jul 20223402
Aug 20222607
Sep 20224408
Oct 20222403
Nov 20224707
Dec 20225109
Jan 20233607
Feb 20232001
Mar 202354015
Apr 20231903
May 2023802
Jun 20231702
Jul 20231508
Aug 20231906
Sep 20231609
Oct 20233303
Nov 20232204
Dec 20233004
Jan 20241702
Feb 20241805
Mar 20241307
Apr 20242209
Total13170399